CDC Quietly Drops Vaccine-Status Discrimination

Researchers performed a placebo-controlled vaccine efficacy trial published at medRxiv last April 2022 to evaluate anti-nucleocapsid antibody (anti-N Ab) seropositivity in Moderna vaccine efficacy after Covid-19 infectionJim Hoft – The Centers for Disease Control and Prevention quietly released new guidelines on the COVID vaccination status this week.

In a news briefing on Thursday, Greta Massetti, chief of the CDC’s Field Epidemiology and Prevention Branch, said, “The current conditions of this pandemic are extremely different from those of the prior two years.”

“High levels of population immunity due to vaccination and previous infection and the many available tools to prevent to the general population and protect people at higher risk allow us to focus on protecting people from serious illness from Covid-19.”

https://twitter.com/backtolife_2023/status/1557821330308960271

For over a year now the CDC, Joe Biden, Dr. Tony Fauci, Democrats, and the WHO demanded the American population from primary school-aged children to senior citizens be vaccinated with the government’s experimental mRNA vaccines.

** Tens of thousands of Americans in both the public and private sectors lost their employment and household income for defying the government demands and regulations.

** Over 29,981 people were reportedly killed by the COVID vaccines according to the Open VAERS website.

** Over 170,000 hospitalizations have been blamed on the vaccines.

On Thursday, the CDC finally admitted that there is no logical reason to treat vaccinated people differently than unvaccinated people when both can readily get and spread the COVID virus.

From the CDC website.

“CDC’s COVID-19 prevention recommendations no longer differentiate based on a person’s vaccination status because breakthrough infections occur, though they are generally mild, and persons who have had COVID-19 but are not vaccinated have some degree of protection against severe illness from their previous infection”

CDC Admits Vaccines Do Not Prevent CV19Earlier this year, the Centers for Disease Control and Prevention (CDC) revealed that unvaccinated people who recovered from COVID-19 were better protected than those who were vaccinated and not previously infected during the recent delta surge, as reported by The Gateway Pundit.

The researchers evaluated the data from 1.1 million Covid-19 cases among adults in California and New York (which account for 18% of the U.S. population) from May 30 to Nov. 20, 2021.

The study was divided into four groups of adults aged 18 above: 1) unvaccinated with no previous laboratory-confirmed COVID-19 diagnosis, 2) unvaccinated with a previous COVID-19 diagnosis, 3) vaccinated (14 days) with no previous COVID-19 diagnosis, and 4) vaccinated with a previous COVID-19 diagnosis.

“When looking at the summer and fall of 2021, when Delta became predominant in this country, however, surviving a previous infection now provided greater protection,” CDC epidemiologist Benjamin Silk said.

The Gateway Pundit reported last October 2021 that 91 clinical research studies all confirmed that natural immunity provides the same if not better protection against the virus than Covid-19 vaccines.

The Gateway Pundit reported last October 2021 that 91 clinical research studies all confirmed that natural immunity provides the same if not better protection against the virus than Covid-19 vaccines.

The Gateway Pundit also reported this year that a new study conducted by scientists from the National Institutes of Health (NIH) and Moderna Inc. showed that mRNA vaccines hurt the long-term immunity to Covid-19 after contracting infection compared to unvaccinated people.

Researchers performed a placebo-controlled vaccine efficacy trial published at medRxiv last April 2022 to evaluate anti-nucleocapsid antibody (anti-N Ab) seropositivity in Moderna vaccine efficacy after Covid-19 infection.

The study analyzed data from 1,789 participants (1,298 placebo recipients and 491 vaccine recipients) with Covid-19 infection at 99 sites in the US during the blinded phase (through March).

The study concludes that anti-nucleocapsid antibody (anti-N Abs) may have lower sensitivity in patients vaccinated with Moderna who become infected. The study also mentioned that the anti-N Ab response in unvaccinated persons has been reported to be durable, with half-life estimates ranging from 68 to 283 days.

SF Source Gateway Pundit Aug 2022

Please leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.